Thermoresponsive polymer colloids for drug delivery and cancer therapy. 2011

Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.

Many difficulties in treating cancer arise from the problems in directing highly cytotoxic agents to the deseased tissues, cells and intracellular compartments. Many drug delivery systems have been devised to address this problem, including those that show a change in properties in response to a temperature stimulus. In particular, colloidal materials based on thermoresponsive polymers offer a means to transport drugs selectively into tumour tissues that are hyperthermic, either intrinsically or through the application of clinical procedures such as localised heating. In this paper, the key attributes of thermoresponsive polymer colloids are considered, a number of important recent examples are discussed and the possible future developments of these materials are evaluated.

UI MeSH Term Description Entries
D008280 Magnetics The study of MAGNETIC PHENOMENA. Magnetic
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011109 Polymethacrylic Acids Poly-2-methylpropenoic acids. Used in the manufacture of methacrylate resins and plastics in the form of pellets and granules, as absorbent for biological materials and as filters; also as biological membranes and as hydrogens. Synonyms: methylacrylate polymer; poly(methylacrylate); acrylic acid methyl ester polymer. Methacrylic Acid Polymers,Acid Polymers, Methacrylic,Acids, Polymethacrylic,Polymers, Methacrylic Acid
D003102 Colloids Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other. Hydrocolloids,Colloid,Hydrocolloid
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000178 Acrylamides Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
October 2022, Expert opinion on drug delivery,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
December 2019, Drug delivery,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
May 2008, Journal of pharmaceutical sciences,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
November 2020, Advances in colloid and interface science,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
November 2012, Future oncology (London, England),
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
May 2023, ACS applied materials & interfaces,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
August 2017, Molecular pharmaceutics,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
April 2006, International journal of pharmaceutics,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
August 2011, Journal of colloid and interface science,
Samer R Abulateefeh, and Sebastian G Spain, and Jonathan W Aylott, and Weng C Chan, and Martin C Garnett, and Cameron Alexander
October 2009, Macromolecular bioscience,
Copied contents to your clipboard!